Motivation: Gene set analysis has become an important tool for the functional interpretation of high-throughput gene expression datasets. Moreover, pattern analyses based on inferred gene set activities of individual samples have shown the ability to identify more robust disease signatures than individual gene-based pattern analyses. Although a number of approaches have been proposed for gene set-based pattern analysis, the combinatorial influence of deregulated gene sets on disease phenotype classification has not been studied sufficiently. Results: We propose a new approach for inferring combinatorial Boolean rules of gene sets for a better understanding of cancer transcriptome and cancer classification. To reduce the search space of the possible Boolean rules, we identify small groups of gene sets that synergistically contribute to the classification of samples into their corresponding phenotypic groups (such as normal and cancer). We then measure the significance of the candidate Boolean rules derived from each group of gene sets; the level of significance is based on the class entropy of the samples selected in accordance with the rules. By applying the present approach to publicly available prostate cancer datasets, we identified 72 significant Boolean rules. Finally, we discuss several identified Boolean rules, such as the rule of glutathione metabolism (down) and prostaglandin synthesis regulation (down), which are consistent with known prostate cancer biology. Availability: Scripts written in Python and R are available at http://biosoft.kaist.ac.kr/∼ihpark/. The refined gene sets and the full list of the identified Boolean rules are provided in the Supplementary
INTRODUCTION
With the advent of microarray technologies, genome-wide gene expression profiling has become a crucial tool in biomedical research during the past few decades. In cancer research, genome-wide gene expression profiling has been used to discover new cancer subtypes (Golub et al., 1999; Lapointe et al., 2004; Sorlie et al., 2003) ; to develop gene expression signatures for cancer diagnosis, prognosis or prediction of drug responsiveness (Nevins and Potti, 2007 ; Potti * To whom correspondence should be addressed.
et van't Veer et al., 2002) ; and to identify cancer associated signaling pathways or cellular processes (Bild et al., 2006; Heiser et al., 2009) .
In a typical analysis of cancer gene expression profiles, individual genes are ranked by the statistical significance of the differential expression between two different experimental conditions; several tens of top-ranked genes are then selected for further analysis, such as cancer classification (Golub et al., 1999; Lapointe et al., 2004; Nevins and Potti, 2007; Potti et al., 2006; Sorlie et al., 2003; van't Veer et al., 2002) and functional enrichment analysis (AlShahrour et al., 2007; Dennis et al., 2003; Huang et al., 2009) . To investigate the combinatorial influences of deregulated genes on disease phenotype classification, researchers have proposed a number of multivariate approaches (Bo and Jonassen, 2002; Mukherjee et al., 2009; Varadan and Anastassiou, 2006) . However, all of these individual gene-based approaches tend to produce unstable gene lists or combinations of genes due to the small sample size used in individual studies (Ambroise et al., 2002; Chuang et al., 2007) .
A recently developed type of gene set analysis aims to directly evaluate the statistical significance of coordinated expression changes of genes belonging to specific pathways or functional categories without selecting an arbitrary number of highly ranked genes in advance, and the gene sets are usually derived from the Gene Ontology (Ashburner et al., 2000) , Kyoto Encyclopedia of Genes and Genomes (KEGG; Kanehisa et al., 2004) , Reactome (Vastrik et al., 2007) , and other knowledge bases. These approaches have the ability to detect gene sets whose constituent genes show 'subtle but coordinated expression changes,' which might not be detected by conventional functional enrichment methods (Dinu et al., 2009; Mootha et al., 2003; Nam and Kim, 2008; Subramanian et al., 2005; Tian et al., 2005) . Moreover, several cancer classification approaches based on the gene set activities inferred from individual samples perform better than other cancer classification approaches based on the expression levels of individual genes (Edelman et al., 2006; Lee et al., 2008a; Levine et al., 2006; Pang et al., 2006) .
Besides the gene set based cancer classification approaches, various other approaches to the study of interdependencies among gene modules have been proposed. Segal et al. (2004 Segal et al. ( , 2003 proposed a module network for learning about transcriptionally coexpressed modules and their dependency structure so that gene expression patterns in different types of cancer could be characterized. That model differs from other gene set dependency models in that it learns about the gene modules and their dependency structure simultaneously from data rather than from predefined gene sets. Tomlins et al. (2006) defined more than 14 000 molecular concepts as gene sets of functionally related genes or differentially expressed genes detected from cancer gene expression datasets; they also constructed a molecular concept map that connects two molecular concepts provided the number of overlapping genes between them is statistically significant. Along with the advantage of the unprecedented large collection of gene sets, the approach of Tomlins et al. (2006) can relate a list of the differentially expressed genes of an experiment to other previously conducted experiments and to the curated concepts. Tomlins et al. (2006) used the molecular concept map to analyze prostate cancer expression profiles, and they could detect enriched subnetworks related to prostate cancer progression models (Tomlins et al., 2006) . However, with their approach there is still a need to select a number of differentially expressed genes between the two experimental conditions, so that enriched subnetworks can be detected; and that requirement makes it difficult to deal with heterogeneous patterns of gene set activities among cancer samples. Pang et al. proposed the use of a random forest algorithm for pathway clustering. They use the genes in each pathway to build a random forest classifier and then use the class votes of each classifier to construct feature vectors of each pathway. The feature vectors are then applied to a tight clustering algorithm for identification of the pathway clusters (Pang et al., 2008) .
Inferring gene set dependency models based on gene set activities inferred for each sample has been proposed recently. Edelman et al. proposed a method of detecting pathway dependencies in prostate cancer progression models with 639 canonical pathways available at the Molecular Signature Database (MSigDB). In their approach, they used ASSESS to measure enrichment scores of pathways in individual samples (Edelman et al., 2006) . They also used the covariance structure of the enrichment scores to infer a pathway dependency structure relevant to the progression models (Edelman et al., 2008) . Although their approach was successful in identifying pathways relevant to the cancer progression models, they have not explicitly used the pathway dependency models to construct predictive models.
In this work, we propose a new approach to the task of inferring combinatorial Boolean rules of gene sets for a better understanding of cancer gene expression profiles as well as cancer classification. To this end, we first identify coherently expressed submodules of each gene set belonging to the 639 canonical pathways available at the MSigDB (Subramanian et al., 2005) and use the submodules as background gene sets for further analysis. Second, we infer gene set activities in individual samples by using gene expression profiles and then binarize them. Third, we construct a gene set synergy network (Watkinson et al., 2008) ; we use that network to search for small groups of synergistic gene sets that provide rich information on the disease status of samples. Finally, we extract significant Boolean rules of the gene sets within each identified group and validate the rules by using independent test datasets. For comparison with other approaches, we use a random forest classifier for classification analysis of the identified Boolean rules (Breiman, 2001 ).
METHODS

Datasets and preprocessing
We analyzed publicly available prostate cancer gene expression datasets with our proposed approach. The datasets of Lapointe et al. (2004) and Yu et al. (2004) HG-U95A 18 65 Tomlins et al. (2006) Spotted cDNA 27 32
The parameters n n and n t are the number of normal samples and cancer samples in a dataset. Singh et al. (2002) were used for learning the Boolean rules of gene sets, and the datasets of Tomlins et al. (2006) and Yu et al. (2004) were used for testing the learned Boolean rules. Table 1 summarizes the properties of the datasets.
Where <20% of the values of the probe set in a dataset were missing, we used the LLSimpute method (Kim et al., 2005) to impute the missing values. Whenever a higher portion of values was missing, we excluded the probe set from the subsequent analysis. We performed quantile normalization among the arrays (Bolstad et al., 2003) , and we finally normalized the expression profile of each probe set to approximate a standard normal distribution across the samples. The expression profiles of the probe sets for each gene were summarized with the mean of their expression values.
Refinement of gene sets
As for gene sets, we downloaded the 639 canonical pathways from the MSigDB (Subramanian et al., 2005) . Because the inclusion of genes that are not coherent with the other genes in a gene set can hinder the performance of our analysis, we redefined the 639 canonical pathways by identifying tightly coregulated submodules in the training datasets.
The coherence of the expression values of a gene set can be measured in a number of ways. One most widely used measurement approaches is to use the fraction of significantly correlated pairs of genes out of all the possible pairs of genes in a gene set (Pilpel et al., 2001) . To identify tightly coregulated submodules for each gene set, we first calculated the pairwise rank correlation coefficients of all the pairs of genes in the gene set. We then constructed a correlation gene network that connects genes that have a significant positive rank correlation coefficient (P < 0.05) and applied a hierarchal graph clustering method called the fitHRG algorithm (Clauset et al., 2008) to the gene correlation network so that we could identify densely connected subnetworks. For each gene set, we selected maximal subnetworks with a connection ratio >0.8. Subnetworks composed of less than three genes were excluded from further analysis. As a result, we obtained 809 gene sets from the analysis of the gene correlation networks derived from the 639 canonical pathways. The redefined gene sets are provided in the Supplementary Materials.
Inference of gene set activity
After assuming that genes in a refined gene set are coherent, we used the normalized mean of expression values as the activity of a gene set in an individual sample. Let z kj be a normalized expression value of a gene, g k , in a sample, j , and let P i be a set of genes. The activity of gene set P i in a sample, j, can then be measured with the following equation (Jiang and Gentleman, 2007; Tian et al., 2005) :
We binarized the activity values of each gene set by using a median binarization method for mining Boolean rules of gene sets. 
Gene set synergy network
To search for interdependency structures among the refined 809 gene sets, we used the recently developed information theoretic measure of synergy to measure the level of cooperativity between all the pair of gene sets. The synergy between two predictive random variables, X and Y , with respect to a dependent random variable, C, which denotes the disease status of a sample in our framework, is defined as follows (Anastassiou, 2007; Hanczar et al., 2007; Watkinson et al., 2008) :
where the I(X;C) is used to denote the mutual information between the two random variables X and C. Thus, the synergy, Syn(X,Y ;C) , can be interpreted as the amount of additional information about C when the two predictive variables X and Y are considered simultaneously rather than individually. To assess the statistical significance of synergy, we use a permutation test that randomly shuffles gene set activities within each class of disease phenotype. As a result, we identified 421 pairs of gene sets that have significant synergy (P < 0.05) as well as significant mutual information with the sample phenotypes (P < 0.05) from the training datasets. Figure 1 shows the synergy network constructed with the pairs of synergistic gene sets. The synergy network shows that prostate cancer related gene sets, namely the glutathione metabolism and O-glycan biosynthesis gene sets, have many synergistic partner gene sets for prostate cancer classification.
Synergistic hierarchical clustering
We searched synergistic clusters of gene sets that have rich information about the sample phenotypes within the synergy network. For this purpose, we constructed dendrograms with the following procedure:
(1) Each gene set is considered an isolated gene set cluster.
(2) The pairwise synergies among the gene set clusters are computed with the Equation (3).
(3) Two clusters that have highest synergy are merged.
(4) Steps 2 and 3 are repeated until only k clusters remain.
Equation (3) is expressed as follows: Fig. 2 . A random distribution of the entropy of the sample phenotypes conditioned on a group of gene sets. We randomly sample 10 000 groups of gene sets for groups of each size.
where PS i ={P i1 ,··· ,P in } and PS j ={P j1 ,··· ,P jm } are sets of gene sets and I(PS i ;C) is an abbreviation of I(P i1 ,··· ,P in ;C). We introduce the parameter α to adjust a bias of synergy towards a negative value when I(PS i ;C) and I(PS j ;C) are large (as shown in the Supplementary Fig. S1 ). A larger α tends to greedily merge two gene set clusters to maximize joint mutual information between sample phenotypes and gene sets in a merged cluster, whereas a smaller α tends to merge two gene set clusters that have a large synergy value between the clusters. We use α = 1,2,··· ,5 to produce gene set dendrograms and select subclusters of gene set dendrograms if the conditional entropy of sample phenotypes is <0.4. (See Fig. 2 for the random distribution of conditional entropy.) We might consider each gene set clusters produced with this approach as co-regulated functional modules in a specific at Periodicals Department/Lane Library on September 22, 2010 bioinformatics.oxfordjournals.org
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Inferring Boolean rules of gene sets phenotype condition but not in all the conditions. The detailed procedure for constructing gene set synergy dendrograms using a hierarchical clustering algorithm is described in the Algorithm 1.
Data: A = (a ij ) is a binarized gene set activity profiles; C = (c j ) denotes the disease status of a sample j. Input: G = (V ;E) is a gene set synergy network described with a set of vertices (gene sets), V , and edges, E, and α is a control parameter of merge process Output: Gene set synergy dendrograms 
Entropy estimation
For a small sample size, the maximum likelihood estimator,Ĥ MLE , tends to underestimate the entropy of observations. When the conditional entropy of sample phenotypes is calculated, the number of samples that fall in each Boolean state of the gene set activities decreases as the number of predictive gene sets increases. To avoid underestimation of the maximum likelihood entropy estimator for such a small sample size, we use the Miller-Madow estimator,Ĥ MM , which is expressed as follows (Paninski et al., 2003) : The term H(C|R i ) denotes the class entropy of samples selected by rule R i . The selected rules (*) are investigated to find known or putative synergistic relations among the gene sets. Table 3 shows the gene sets that appear in the rules.
With Equation (4), the bias of the maximum likelihood estimator,Ĥ MLE , can be corrected by adding the estimated bias term
, where is the number of possible observations (that is, normal and cancer) and m is the number of samples within each Boolean condition of the gene set activities. We use n i andp i to denote the number of samples and estimated probability in each phenotypic state under a Boolean condition of gene set activities.
RESULTS AND DISCUSSION
Boolean rules of synergistic gene sets
Synergistic hierarchical clustering methods identified 31 groups of synergistic gene sets with a low threshold of conditional entropy; i.e. H(C|P i1 ,··· ,P ik ) < 0.4. From each identified small group of gene sets, we were able to extract significant Boolean rules by evaluating the significance of all the possible conjunctive Boolean functions.
Validation with independent datasets
We validated the identified Boolean rules by using the datasets of Tomlins et al. (2006) and Yu et al. (2004) . To quantify the level of agreement between the Boolean rules and the gene expression profiles of each test dataset, we devised a following scheme from the log-rank sum approach (Breitling et al., 2004) .
With the Boolean rule R = (P p1 ∧···∧P pk )∧(¬P n1 ∧···∧¬P nm ), we divided the literals into PL ={P p1 ,...,P pk } and NL = {P n1 ,...,P nm } to, respectively, represent the sets of gene sets that positively and negatively participate in the rule. We then constructed rank profiles for each element of PL and NL in ascending and descending order, respectively. Finally, we calculated the sum of the log-ranks from the rank profiles of the literals for each sample. To test the significance of each rule, we performed a rank-sum test for the sum of the log-ranks of the literals of the normal and cancer samples. Table 2 shows top 20 Boolean rules validated from the test datasets; Table 3 shows the gene sets that appear in the selected rules. Several selected rules are discussed below. Figure 3 shows scatter plots of samples; these plots are based on the activities of the gene sets included in the most significant rules, R 1 and R 2 .
• R 1 : glutathione metabolism (down) and prostaglandin synthesis regulation (down) The glutathione s-transferases (GSTs) are known to be involved in the metabolism of carcinogens and in the defense against reactive oxygen species. Moskaluk et al. (1997) confirmed the down-regulation of π-class GSTs in adenocarcinoma of the prostate. In many types of cancer, COX-2 is known to be overexpressed, and the overexpression of COX-2 leads overproduction of prostaglandin E2 (Eruslanov et al., 2009) . Note also that the highly selective inhibitor of COX-2, celecoxib, has been researched for use in cancer treatments as a supplement to pain treatments. Our analysis shows no significant change in the COX-2 expression level for the prostate cancer samples, though the other member genes PTGER2, PTGIS, EDNRA, and EDNRB are significantly down-regulated. (Jakobsson et al., 1999) identified a glutathione-dependent prostaglandin E synthase, which might be a cause of the down-regulation of prostaglandin synthesis regulation in the primary prostate cancer. Recently, GSTP1 and PTGDS have been proposed as key molecules in prostate cancer classification (Varadan and Anastassiou, 2006; Watkinson et al., 2008) .
• R 2 : insulin-dependent diabetes mellitus (up) and transforming growth factor (TGF )-β-dependent SMAD signaling (down) The association of prostate cancer risk and insulin-dependent diabetes has been reported in several population-based studies (Hsing et al., 2001; Pierce et al., 2008) . In our analysis, the submodule of insulin-dependent diabetes mellitus that contains ICA1, PTPRN2, and CPE shows a higher level of activation in primary prostate cancer. On the other hand, an androgen receptor (AR) has been known to negatively modulate TGF-β-dependent SMAD signalling in AR-dependent prostate cancer (van der Poel et al., 2005) ; thus TGF-β-dependent SMAD signalling is down-regulated in AR-dependent prostate cancer. Interestingly, Lin et al. (2009) reported that the TGF-β signalling effector SMAD3 represses insulin gene transcription in pancreatic islet cells.
• R 6 : purine metabolism (up) and nicotine and nicotinate metabolism (down) Alteration of the purine metabolism either facilitates production or retards degradation of adenosine, which is the main element of ATP (Linden et al., 2006) . Obajimi et al. (2009) showed that inhibition of de novo purine synthesis in LNCaP cells results in ATP depletion. On the other hand, the nicotin and nicotinate metabolism, which includes AOX1 and NTE5, is related to antioxidation of reactive oxygen species (Dong et al., 2008) , and those genes show significantly decreased expression patterns in the primary prostate cancer.
• R 9 : DNA replication (up) and G1 pathway (down) AR has been suggested as a licensing factor for DNA replication in androgen-sensitive prostate cancer cells ( Litvinov et al., 2006) ; in addition, the DNA replication regulation protein MCM7 has been suggested for use as a proliferation marker in prostate cancer (Padmanabhan et al., 2004) . On the other hand, the G1 pathway is an important checkpoint of cell proliferation. Thus, the tumor cells undergo uncontrolled proliferation by destroying the G1 pathway while activating the DNA replication pathway.
• R 18 : complement and coagulation (down), calmodulin (down) and TERT pathway (up) The genes SERPINA5 and SERPING1, which are involved in the complement and coagulation pathway, are important for preventing cancer cell growth and metastasis in breast and prostate cancer (Sieben et al., 2005) . Calmodulin is known as a negative modulator of ARs, which play an important role in AR breakage (Cifuentes et al., 2004) . Therefore, the loss of expression of those genes promotes the development of prostate cancer. In the TERT pathway, the genes HDAC1, MYC, MZF1 and SP3 show higher expression levels in prostate cancer; they contribute to the survival and proliferation of cancer cells (Lee et al., 2008b) .
Classification analysis
We used the discovered Boolean rules of the gene sets to perform classification analysis. We obtained feature vectors in individual samples for the Boolean rules with the log-rank sum of literals in the rule described in the previous section, and we constructed random forest classifiers (Breiman, 2001 ) for the test datasets by using the features selected from the training datasets. Using the cross-validation errors and the area under the curve (as shown in Fig. 4) , we compared the overall classification performances with the classification based on the genes and gene sets. For independent datasets, our results are comparable the classification based on genes and gene sets.
CONCLUSION
We have presented a method of inferring Boolean rules of gene sets from cancer microarray datasets. We first identified small subsets of gene sets that are synergistic; we then enumerated all the possible conjunctive Boolean functions of the gene sets within each group of gene sets; and, finally, we evaluated the predictive powers of the Boolean functions. Although several approaches have been proposed to reveal the Boolean logic of individual molecules (Ruczinski et al., 2003; Mukherjee et al., 2009; Varadan and Anastassiou, 2006) , our method is different with those methods in that we try to identify relevant variables by using a synergy network before we search for the Boolean rules. We have identified and discussed several significant Boolean rules of gene sets that are frequently observed in prostate cancer. Our results show the possibility of using Boolean rules of gene sets for cancer classification, and the identified Boolean rules provide insights into the combinatorial influences of deregulated gene sets on cancer developments. The coverage of gene set analysis increases as the information on pathway interactions is accumulated. Thus, further research directions should include the pathway interaction information for the dissection of coherent submodules in a gene set. Conflict of Interest: none declared.
